Literature DB >> 21883814

Functional results and patient satisfaction with sacral nerve stimulation for idiopathic faecal incontinence.

J Duelund-Jakobsen1, B van Wunnik, S Buntzen, L Lundby, C Baeten, S Laurberg.   

Abstract

AIM: Sacral nerve stimulation (SNS) is an established treatment for faecal incontinence (FI) when conservative modalities have failed to restore continence. This two-centre study aimed to document functional outcome and its relationship to patient satisfaction.
METHOD: Patients treated with SNS for idiopathic FI in Aarhus (Denmark) and Maastricht (The Netherlands) were included. At the most recent follow-up appointment, 127 patients (80%) were identified as receiving active SNS therapy. A questionnaire considering bowel habits, quality of life, and self-reported satisfaction and a 3-week bowel-habit diary were mailed to these patients, and 85% responded.
RESULTS: Patient satisfaction was clearly related to the number of FI episodes. Patients experiencing full continence were all satisfied, and although the satisfaction rate decreased as the number of FI episodes increased, 46% of the patients with more FI episodes at follow-up than at baseline were still satisfied. Per-protocol analysis resulted in a satisfaction rate of 57.3%. In total, 74.7% of the patients receiving active SNS therapy reported a reduction of ≥ 50% in FI episodes, 10.3% of whom were dissatisfied after a median of 46 months of follow-up.
CONCLUSION: There is a clear relationship between patient satisfaction and improved continence. A total of 57.3% of the patients offered SNS therapy were satisfied at follow-up. However, 46% of the patients with more FI episodes at follow-up than at baseline were also satisfied. Therefore, functional outcome of SNS therapy cannot be based only on bowel-habit diaries and bowel scores.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2012        PMID: 21883814     DOI: 10.1111/j.1463-1318.2011.02800.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  13 in total

Review 1.  Neuromodulation for fecal incontinence: an effective surgical intervention.

Authors:  Giuseppe Chiarioni; Olafur S Palsson; Corrado R Asteria; William E Whitehead
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

Review 2.  [Sacral nerve modulation in coloproctology].

Authors:  M Gelos; M Niedergethmann
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

Review 3.  Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes.

Authors:  Julie Ann M Van Koughnett; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

4.  Adverse events of sacral neuromodulation for fecal incontinence reported to the federal drug administration.

Authors:  Klaus Bielefeldt
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

Review 5.  Faecal incontinence: Current knowledges and perspectives.

Authors:  Alban Benezech; Michel Bouvier; Véronique Vitton
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

6.  Baseline factors predictive of patient satisfaction with sacral neuromodulation for idiopathic fecal incontinence.

Authors:  Jakob Duelund-Jakobsen; Bart van Wunnik; Steen Buntzen; Lilli Lundby; Søren Laurberg; Cor Baeten
Journal:  Int J Colorectal Dis       Date:  2014-04-18       Impact factor: 2.571

Review 7.  Management of patients with faecal incontinence.

Authors:  Jakob Duelund-Jakobsen; Jonas Worsoe; Lilli Lundby; Peter Christensen; Klaus Krogh
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

8.  Anatomical disruption and length-tension dysfunction of anal sphincter complex muscles in women with fecal incontinence.

Authors:  Young Sun Kim; Milena Weinstein; Varuna Raizada; Yanfen Jiang; Valmik Bhargava; M Raj Rajasekaran; Ravinder K Mittal
Journal:  Dis Colon Rectum       Date:  2013-11       Impact factor: 4.585

9.  Sacral neuromodulation for fecal incontinence and "low anterior resection syndrome" following neoadjuvant therapy for rectal cancer.

Authors:  O Schwandner
Journal:  Int J Colorectal Dis       Date:  2013-04-05       Impact factor: 2.571

10.  Sacral neuromodulation for bowel dysfunction: a consensus statement from the Italian group.

Authors:  E Falletto; E Ganio; G Naldini; C Ratto; D F Altomare
Journal:  Tech Coloproctol       Date:  2013-04-06       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.